The Breast Cancer Gene Panel Test is a genetic test designed to identify inherited gene variants associated with an increased risk of breast cancer and, depending on the genes included, certain other cancers.
The test may help assess hereditary cancer susceptibility, particularly in individuals with a personal or family history of breast cancer. Results can support genetic counselling, personalized screening recommendations, and preventive healthcare decisions.
Important: This test evaluates inherited cancer risk. It does not diagnose existing breast cancer, and a negative result does not eliminate the possibility of developing cancer.
Fasting
Not required
Report time
As per laboratory processing time
Recommended for
Male & Female
Age group
18–99 years
Parameters
1 parameters
1.Breast Cancer Gene Panel
Analyzes selected genes (such as BRCA1, BRCA2, PALB2, CHEK2, ATM, TP53 and PTEN, depending on the laboratory panel) for inherited variants linked to breast cancer risk.
Also known as: Hereditary Breast Cancer Genetic Test, Breast Cancer Genetic Screening, Hereditary Breast Cancer Panel, Breast Cancer Susceptibility Gene Panel
The Breast Cancer Gene Panel Test is a genetic investigation used to assess inherited susceptibility to breast cancer.
Breast cancer can develop due to a combination of genetic, hormonal, environmental, and other factors. Most breast cancers are not caused by an inherited high-risk gene variant. However, some individuals inherit genetic changes that substantially increase their lifetime risk of developing certain cancers.
Hereditary breast cancer testing may identify pathogenic or likely pathogenic variants in genes associated with cancer susceptibility.
Commonly evaluated genes in hereditary breast cancer panels may include:
The Breast Cancer Gene Panel Test may be appropriate for:
The test uses a blood or saliva sample, depending on the laboratory.
Before the test:
| Parameter | Normal range |
|---|---|
| Genetic panel result | reported as Pathogenic / Likely Pathogenic variant, Variant of Uncertain Significance (VUS), or No pathogenic variant detected. |
| Note | This test has no numeric reference range. The genes analyzed, the methodology and the variants detected depend on the partner laboratory's panel. Results should be reviewed with a qualified genetics professional together with personal and family history. A negative result does not eliminate cancer risk. |
Reference ranges can differ between labs. Your report shows the range used by the lab.
It is a genetic test that examines selected genes associated with inherited breast cancer susceptibility.
No. It assesses inherited cancer risk and does not diagnose an existing breast tumor.
No. Fasting is not required.
Many hereditary breast cancer panels include BRCA1 and BRCA2, but their inclusion in this specific panel must be confirmed with the laboratory.
| Test name | Breast Cancer Gene Panel Test |
|---|---|
| Location | Chennai |
| Sample type | Blood |
| Number of parameters | 1 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | As per laboratory processing time |
| Recommended age | 18–99 years |
| Suitable for | Male & Female |
These are examples of genes that may be included in hereditary cancer panels. Their inclusion in this specific test has not been confirmed. The exact genes analyzed, testing methodology, and types of genetic variants detected depend on the partner laboratory's panel.
Genetic testing is most useful when selected and interpreted with professional genetic counselling.
Healthcare professionals may recommend this test to:
Benefits of the Breast Cancer Gene Panel Test:
Note: Testing unaffected relatives is often most informative when a known familial pathogenic variant has already been identified. Genetic counselling can help determine the appropriate test.
Yes. Men can inherit and pass on cancer-associated genetic variants and may benefit from testing when clinically indicated.
No. A pathogenic variant may increase cancer risk, but it does not guarantee that cancer will develop.
No. A negative result does not eliminate cancer risk. Its interpretation depends on the genes tested and personal and family history.
A VUS is a genetic change for which there is insufficient evidence to determine whether it increases disease risk.
Yes. Identifying an inherited pathogenic variant may provide information relevant to biological relatives and their genetic counselling.
Pre-test and post-test genetic counselling are strongly recommended to understand the benefits, limitations, and implications of testing.
It may be appropriate in selected circumstances, but routine testing of everyone is not generally recommended. A healthcare professional can assess whether testing is indicated.
Genetic testing commonly uses blood or saliva. The exact sample requirement must be confirmed with the partner laboratory.
Booking and sample collection depend on the partner laboratory's availability, eligibility requirements, consent procedures, and sample collection arrangements.
Turnaround time depends on the genetic testing laboratory and the testing methodology. Confirm the expected reporting time before booking.
Inherited DNA variants generally remain unchanged throughout life, so repeating the same comprehensive genetic test is usually unnecessary. Additional testing may sometimes be appropriate as technology and clinical knowledge evolve.
| City Name | Prices |
|---|---|
| Breast Cancer Gene Panel Test in Agra | ₹24,000 |
| Breast Cancer Gene Panel Test in Ahmedabad | ₹24,000 |
| Breast Cancer Gene Panel Test in Ajmer | ₹24,000 |
| Breast Cancer Gene Panel Test in Aligarh | ₹24,000 |
| Breast Cancer Gene Panel Test in Amravati | ₹24,000 |